Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel O'Reilly

Showing results (21-30 of 74) with videos related to

Pageof 8
Sort By:
European Journal of Pediatrics|October 14, 2025
Acute kidney injury in infants with necrotising enterocolitis: A case-control studyDermot Wildes, Brian Patrick Cleary, Ciara Terry, et al.
Nature Reviews. Drug Discovery|December 17, 2024
Chemical engineering of CRISPR-Cas systems for therapeutic applicationHalle M Barber, Adrian A Pater, Keith T Gagnon, et al.
Biochemical Pharmacology|March 1, 2021
Small nucleic acids and the path to the clinic for anti-CRISPRChristopher L Barkau, Daniel O'Reilly, Seth B Eddington, et al.
Research and Practice in Thrombosis and Haemostasis|December 17, 2024
Maternal thrombocytopenia is not predictive of neonatal thrombocytopenia: a single-center Irish studyLigia Nechifor, Daniel O'Reilly, John O'Loughlin, et al.
Pediatric Research|November 14, 2025
The role of machine learning in autism spectrum disorder assessment and managementAoife Reilly, Nicola Walsh, Daniel O'Reilly, et al.
BMJ Paediatrics Open|March 6, 2025
Carbon emissions from road transport on a national neonatal transport service: a retrospective observational studyCarmel Maria Moore, Daniel O'Reilly, Nurul Aminudin, et al.
Nucleic Acid Therapeutics|April 17, 2019
Rationally Designed Anti-CRISPR Nucleic Acid Inhibitors of CRISPR-Cas9Christopher L Barkau, Daniel O'Reilly, Kushal J Rohilla, et al.
Nucleic Acid Therapeutics|January 24, 2022
17th Annual Meeting of the Oligonucleotide Therapeutics Society: A Tribute to Bob Letsinger, Progress in <i>N</i> = 1 Treatments, and Successful First In-Humans CRISPR TrialsRonald A M Buijsen, Aurélie Lacroix, Joseph Ochaba, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|April 20, 2026
Area level measures of socioeconomic deprivation and their impact on very preterm birth and very preterm birth outcomes: A retrospective cohort studyDaniel O'Reilly, Lauren Murphy, Sharon Dempsey, et al.
Biochemistry|December 7, 2018
Next-Generation Peptide Nucleic Acid Chimeras Exhibit High Affinity and Potent Gene SilencingAlexandre J Debacker, Vivek K Sharma, Pranathi Meda Krishnamurthy, et al.
Pageof 8

Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
European Journal of Pediatrics|October 14, 2025
Acute kidney injury in infants with necrotising enterocolitis: A case-control studyDermot Wildes, Brian Patrick Cleary, Ciara Terry, et al.
Nature Reviews. Drug Discovery|December 17, 2024
Chemical engineering of CRISPR-Cas systems for therapeutic applicationHalle M Barber, Adrian A Pater, Keith T Gagnon, et al.
Biochemical Pharmacology|March 1, 2021
Small nucleic acids and the path to the clinic for anti-CRISPRChristopher L Barkau, Daniel O'Reilly, Seth B Eddington, et al.
Research and Practice in Thrombosis and Haemostasis|December 17, 2024
Maternal thrombocytopenia is not predictive of neonatal thrombocytopenia: a single-center Irish studyLigia Nechifor, Daniel O'Reilly, John O'Loughlin, et al.
Pediatric Research|November 14, 2025
The role of machine learning in autism spectrum disorder assessment and managementAoife Reilly, Nicola Walsh, Daniel O'Reilly, et al.
BMJ Paediatrics Open|March 6, 2025
Carbon emissions from road transport on a national neonatal transport service: a retrospective observational studyCarmel Maria Moore, Daniel O'Reilly, Nurul Aminudin, et al.
Nucleic Acid Therapeutics|April 17, 2019
Rationally Designed Anti-CRISPR Nucleic Acid Inhibitors of CRISPR-Cas9Christopher L Barkau, Daniel O'Reilly, Kushal J Rohilla, et al.
Nucleic Acid Therapeutics|January 24, 2022
17th Annual Meeting of the Oligonucleotide Therapeutics Society: A Tribute to Bob Letsinger, Progress in <i>N</i> = 1 Treatments, and Successful First In-Humans CRISPR TrialsRonald A M Buijsen, Aurélie Lacroix, Joseph Ochaba, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|April 20, 2026
Area level measures of socioeconomic deprivation and their impact on very preterm birth and very preterm birth outcomes: A retrospective cohort studyDaniel O'Reilly, Lauren Murphy, Sharon Dempsey, et al.
Biochemistry|December 7, 2018
Next-Generation Peptide Nucleic Acid Chimeras Exhibit High Affinity and Potent Gene SilencingAlexandre J Debacker, Vivek K Sharma, Pranathi Meda Krishnamurthy, et al.
Pageof 8